Paul Tudor Jones's ELV Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 25,499 shares of Elevance Health, Inc. (ELV) worth $7.46 M, representing 0.01% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 40 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in ELV, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2015, adding 135,936 shares. Largest reduction occurred in Q2 2015, reducing 130,543 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Elevance Health (ELV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elevance Health (ELV) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +25,499 | New Buy | 25,499 | $292.75 |
| Q4 2025 | -77,687 | Sold Out | 0 | $0.00 |
| Q3 2025 | +77,687 | New Buy | 77,687 | $323.12 |
| Q1 2025 | -37,049 | Sold Out | 0 | $0.00 |
| Q4 2024 | -4,129 | Reduce 10.03% | 37,049 | $368.90 |
| Q3 2024 | +41,178 | New Buy | 41,178 | $520.00 |
| Q4 2023 | -2,994 | Sold Out | 0 | $0.00 |
| Q3 2023 | -12,376 | Reduce 80.52% | 2,994 | $435.42 |
| Q2 2023 | +11,368 | Add 284.06% | 15,370 | $444.29 |
| Q1 2023 | +4,002 | New Buy | 4,002 | $0.46 |
| Q4 2022 | -41,368 | Sold Out | 0 | $0.00 |
| Q3 2022 | +13,515 | Add 48.52% | 41,368 | $454.24 |
| Q2 2022 | +24,356 | Add 696.48% | 27,853 | $482.57 |
| Q1 2022 | +3,497 | New Buy | 3,497 | $491.28 |
| Q4 2021 | -3,268 | Sold Out | 0 | $0.00 |
| Q3 2021 | -7,584 | Reduce 69.89% | 3,268 | $372.71 |
| Q2 2021 | +10,852 | New Buy | 10,852 | $381.77 |
| Q1 2021 | -6,586 | Sold Out | 0 | $0.00 |
| Q4 2020 | -6,109 | Reduce 48.12% | 6,586 | $321.14 |
| Q3 2020 | -1,878 | Reduce 12.89% | 12,695 | $268.61 |
| Q2 2020 | +5,659 | Add 63.48% | 14,573 | $262.95 |
| Q1 2020 | -5,010 | Reduce 35.98% | 8,914 | $227.06 |
| Q4 2019 | -32,844 | Reduce 70.23% | 13,924 | $302.00 |
| Q3 2019 | +46,768 | New Buy | 46,768 | $240.10 |
| Q2 2019 | -9,151 | Sold Out | 0 | $0.00 |
| Q1 2019 | +9,151 | New Buy | 9,151 | $286.96 |
| Q1 2018 | -11,904 | Sold Out | 0 | $0.00 |
| Q4 2017 | +767 | Add 6.89% | 11,904 | $225.05 |
| Q3 2017 | -1,261 | Reduce 10.17% | 11,137 | $189.91 |
| Q2 2017 | +9,798 | Add 376.85% | 12,398 | $188.09 |
| Q1 2017 | -2,200 | Reduce 45.83% | 2,600 | $165.38 |
| Q4 2016 | +4,800 | New Buy | 4,800 | $143.75 |
| Q3 2016 | -15,254 | Sold Out | 0 | $0.00 |
| Q2 2016 | +12,854 | Add 535.58% | 15,254 | $131.31 |
| Q1 2016 | -2,000 | Reduce 45.45% | 2,400 | $139.17 |
| Q4 2015 | -9,767 | Reduce 68.94% | 4,400 | $139.55 |
| Q3 2015 | -12,190 | Reduce 46.25% | 14,167 | $139.97 |
| Q2 2015 | -130,543 | Reduce 83.20% | 26,357 | $164.13 |
| Q1 2015 | +135,936 | Add 648.43% | 156,900 | $154.41 |
| Q4 2014 | +20,964 | New Buy | 20,964 | $125.69 |
Paul Tudor Jones's Elevance Health Investment FAQs
Paul Tudor Jones first purchased Elevance Health, Inc. (ELV) in Q4 2014, acquiring 20,964 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Elevance Health, Inc. (ELV) for 40 quarters since Q4 2014.
Paul Tudor Jones's largest addition to Elevance Health, Inc. (ELV) was in Q1 2015, adding 156,900 shares worth $24.23 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 25,499 shares of Elevance Health, Inc. (ELV), valued at approximately $7.46 M.
As of the Q1 2026 filing, Elevance Health, Inc. (ELV) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Elevance Health, Inc. (ELV) was 156,900 shares, as reported at the end of Q1 2015.